Replies to post #145013 on Biotech Values

[DewDiligence]

MNTA—Thanks for the blurb on Dr. Keith Flaherty, who is quoted in #msg-77147254 as a proponent of MNTA’s heparin-based approach to cancer.

p.s. The 2010 NYT article that focused on Flaherty’s work with Zelboraf is in #msg-46899517.